Display options
Cite
Koopman JP, Egesa M, Wajja A, et al. Risk assessment for the implementation of controlled human . AAS Open Res. 2019;2:17doi: 10.12688/aasopenres.12972.2.
Koopman, J. P., Egesa, M., Wajja, A., Adriko, M., Nassuuna, J., Nkurunungi, G., Driciru, E., van Willigen, G., Cose, S., Yazdanbakhsh, M., Kaleebu, P., Kabatereine, N., Tukahebwa, E., Roestenberg, M., & Elliott, A. M. (2019). Risk assessment for the implementation of controlled human . AAS open research, 217. https://doi.org/10.12688/aasopenres.12972.2
Koopman, Jan Pieter, et al. "Risk assessment for the implementation of controlled human ." AAS open research vol. 2 (2019): 17. doi: https://doi.org/10.12688/aasopenres.12972.2
Koopman JP, Egesa M, Wajja A, Adriko M, Nassuuna J, Nkurunungi G, Driciru E, van Willigen G, Cose S, Yazdanbakhsh M, Kaleebu P, Kabatereine N, Tukahebwa E, Roestenberg M, Elliott AM. Risk assessment for the implementation of controlled human . AAS Open Res. 2019 Aug 13;2:17. doi: 10.12688/aasopenres.12972.2. eCollection 2019. PMID: 31819922; PMCID: PMC6901351.
Copy Download .nbib Format: NLM
Share it on

AAS Open Res. 2019 Aug 13;2:17. doi: 10.12688/aasopenres.12972.2. eCollection 2019.

Risk assessment for the implementation of controlled human .

AAS open research

Jan Pieter Koopman, Moses Egesa, Anne Wajja, Moses Adriko, Jacent Nassuuna, Gyaviira Nkurunungi, Emmanuella Driciru, Gijsbert van Willigen, Stephen Cose, Maria Yazdanbakhsh, Pontiano Kaleebu, Narcis Kabatereine, Edridah Tukahebwa, Meta Roestenberg, Alison M Elliott

Affiliations

  1. Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.
  2. Uganda Virus Research Institute, Entebbe, Uganda.
  3. Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  4. Vector Control Division, Ministry of Health of Uganda, Kampala, Uganda.
  5. Department of Health, Safety and the Environment, Leiden University Medical Center, Leiden, The Netherlands.
  6. Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK.

PMID: 31819922 PMCID: PMC6901351 DOI: 10.12688/aasopenres.12972.2

Abstract

Schistosomiasis is a parasitic infection highly prevalent in sub-Saharan Africa, and a significant cause of morbidity; it is a priority for vaccine development. A controlled human infection model for

Copyright: © 2019 Koopman JP et al.

Keywords: Controlled Human Infection Studies; Schistosoma mansoni; Uganda; risk assessment

Conflict of interest statement

Competing interests: The authors have declared no personal financial competing interests. However, we are working collaboratively to develop the CHI-S for implementation in Uganda, and therefore have

References

  1. Ann Intern Med. 2019 May 21;170(10):732-733 - PubMed
  2. Malar J. 2015 Apr 28;14:182 - PubMed
  3. J Clin Invest. 2014 Jul;124(7):3147-58 - PubMed
  4. Evolution. 1991 Aug;45(5):1136-1146 - PubMed
  5. Wellcome Open Res. 2018 Apr 11;3:39 - PubMed
  6. PLoS Negl Trop Dis. 2010 Mar 23;4(3):e637 - PubMed
  7. Science. 2016 Jan 1;351(6268):16-9 - PubMed
  8. PLoS Negl Trop Dis. 2017 Oct 4;11(10):e0005953 - PubMed
  9. Wellcome Open Res. 2018 Nov 1;3:141 - PubMed
  10. Lancet. 2014 May 17;383(9930):1707-8 - PubMed
  11. Lancet. 2014 Jun 28;383(9936):2253-64 - PubMed
  12. Acta Trop. 2013 Nov;128(2):303-8 - PubMed
  13. AAS Open Res. 2018 Apr 18;1:2 - PubMed
  14. Clin Infect Dis. 2016 Nov 1;63(9):1151-1159 - PubMed
  15. J Infect Dis. 2018 Aug 24;218(7):1142-1146 - PubMed

Publication Types

Grant support